跳至主要内容
临床试验/NCT04512898
NCT04512898Unknown4 期

Effect of Helicobacter Pylori Eradication on Symptoms and Quality of Life of Irritable Bowel Syndrome: A Prospective Study

Assiut University0 个研究点目标入组 100 人开始时间: 2020年8月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
100
主要终点
Questionnaire for Rome IV criteria

研究概览

简要总结

H. Pylori is frequently observed in patients with irritable bowel syndrome(IBS). However, the effect of H. pylori eradication on IBS is not clear.

详细描述

Patients with IBS symptoms using Rome IV criteria will be included. Testing for H. pylori will be done. Patients with H. pylori will receive triple therapy and followed after two weeks for eradication and assessment of IBS symptoms.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients newly diagnosed with IBS and H.pylori

排除标准

  • Patients received previous treatment of H.pylori
  • Patients receiving treatment for IBS.

研究组 & 干预措施

Patient with IBS

Experimental

Patients with IBS and positive H. pylori.

干预措施: Triple therapy for H.pylori (Drug)

结局指标

主要结局

Questionnaire for Rome IV criteria

时间窗: 2 weeks

Symptoms of IBS

次要结局

  • Quality of life questionnaire(2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Haidi Karam

Lecturer of Tropical Medicine and Gastroenterology

Assiut University

相似试验